While cases of RSV, the flu, and Covid-19 have somewhat subsided, there has been a significant surge in cases of metapneumovirus (HMPV), with a 36% increase reported this year.
According to the CDC, HMPV can cause respiratory diseases affecting both the upper and lower respiratory tracts, primarily impacting young children and older adults.
Upper respiratory infections may present with milder symptoms such as runny nose, sore throat, and coughing, while infections deeper in the respiratory tract can lead to more severe conditions like bronchitis or pneumonia.
Currently, there is no vaccine or antiviral medication available for HMPV, and the recommended approach is to let the virus run its course while managing symptoms.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].